16-725947-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001378030.1(CCDC78):​c.180+19C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.235 in 1,564,226 control chromosomes in the GnomAD database, including 46,126 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.20 ( 3372 hom., cov: 33)
Exomes 𝑓: 0.24 ( 42754 hom. )

Consequence

CCDC78
NM_001378030.1 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.902

Publications

7 publications found
Variant links:
Genes affected
CCDC78 (HGNC:14153): (coiled-coil domain containing 78) Involved in de novo centriole assembly involved in multi-ciliated epithelial cell differentiation and skeletal muscle contraction. Located in several cellular components, including centriole; deuterosome; and sarcolemma. Implicated in centronuclear myopathy 4. [provided by Alliance of Genome Resources, Apr 2022]
CCDC78 Gene-Disease associations (from GenCC):
  • congenital myopathy with internal nuclei and atypical cores
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • centronuclear myopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 16-725947-G-C is Benign according to our data. Variant chr16-725947-G-C is described in ClinVar as Benign. ClinVar VariationId is 257165.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.304 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001378030.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CCDC78
NM_001378030.1
MANE Select
c.180+19C>G
intron
N/ANP_001364959.1
CCDC78
NM_001031737.3
c.180+19C>G
intron
N/ANP_001026907.2
CCDC78
NM_001378031.1
c.180+19C>G
intron
N/ANP_001364960.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CCDC78
ENST00000345165.10
TSL:5 MANE Select
c.180+19C>G
intron
N/AENSP00000316851.5
CCDC78
ENST00000293889.10
TSL:1
c.180+19C>G
intron
N/AENSP00000293889.6
CCDC78
ENST00000650995.1
c.402+19C>G
intron
N/AENSP00000498860.1

Frequencies

GnomAD3 genomes
AF:
0.198
AC:
30069
AN:
151904
Hom.:
3366
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.126
Gnomad AMI
AF:
0.271
Gnomad AMR
AF:
0.153
Gnomad ASJ
AF:
0.183
Gnomad EAS
AF:
0.0127
Gnomad SAS
AF:
0.315
Gnomad FIN
AF:
0.258
Gnomad MID
AF:
0.168
Gnomad NFE
AF:
0.249
Gnomad OTH
AF:
0.184
GnomAD2 exomes
AF:
0.212
AC:
36866
AN:
173960
AF XY:
0.224
show subpopulations
Gnomad AFR exome
AF:
0.129
Gnomad AMR exome
AF:
0.108
Gnomad ASJ exome
AF:
0.175
Gnomad EAS exome
AF:
0.00834
Gnomad FIN exome
AF:
0.267
Gnomad NFE exome
AF:
0.254
Gnomad OTH exome
AF:
0.211
GnomAD4 exome
AF:
0.239
AC:
337391
AN:
1412204
Hom.:
42754
Cov.:
38
AF XY:
0.242
AC XY:
169058
AN XY:
698392
show subpopulations
African (AFR)
AF:
0.122
AC:
3927
AN:
32272
American (AMR)
AF:
0.111
AC:
4182
AN:
37656
Ashkenazi Jewish (ASJ)
AF:
0.179
AC:
4550
AN:
25394
East Asian (EAS)
AF:
0.0221
AC:
818
AN:
37070
South Asian (SAS)
AF:
0.320
AC:
26018
AN:
81390
European-Finnish (FIN)
AF:
0.265
AC:
12851
AN:
48476
Middle Eastern (MID)
AF:
0.154
AC:
880
AN:
5714
European-Non Finnish (NFE)
AF:
0.250
AC:
271532
AN:
1085776
Other (OTH)
AF:
0.216
AC:
12633
AN:
58456
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
13919
27838
41758
55677
69596
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9088
18176
27264
36352
45440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.198
AC:
30100
AN:
152022
Hom.:
3372
Cov.:
33
AF XY:
0.199
AC XY:
14796
AN XY:
74318
show subpopulations
African (AFR)
AF:
0.126
AC:
5250
AN:
41520
American (AMR)
AF:
0.153
AC:
2339
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.183
AC:
636
AN:
3468
East Asian (EAS)
AF:
0.0129
AC:
67
AN:
5184
South Asian (SAS)
AF:
0.317
AC:
1524
AN:
4810
European-Finnish (FIN)
AF:
0.258
AC:
2727
AN:
10578
Middle Eastern (MID)
AF:
0.180
AC:
53
AN:
294
European-Non Finnish (NFE)
AF:
0.249
AC:
16871
AN:
67868
Other (OTH)
AF:
0.184
AC:
387
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1225
2449
3674
4898
6123
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
328
656
984
1312
1640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.152
Hom.:
466
Bravo
AF:
0.181

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 15, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Congenital myopathy with internal nuclei and atypical cores Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
4.3
DANN
Benign
0.26
PhyloP100
-0.90
PromoterAI
-0.0028
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12446058; hg19: chr16-775947; COSMIC: COSV52402257; COSMIC: COSV52402257; API